BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6208797)

  • 1. CSF neurochemistry of women with anorexia nervosa and normal women.
    Gerner RH; Cohen DJ; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Shaywitz BA; Hare TA
    Am J Psychiatry; 1984 Nov; 141(11):1441-4. PubMed ID: 6208797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
    Gerner RH; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Hare TA; Shaywitz BA; Cohen DJ
    Am J Psychiatry; 1984 Dec; 141(12):1533-40. PubMed ID: 6209989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA; Bowden CL; Maas JW
    J Chromatogr; 1984 Dec; 336(2):259-69. PubMed ID: 6085084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF monoamine metabolites of depressed patients during illness and after recovery.
    Träskman-Bendz L; Asberg M; Bertilsson L; Thorén P
    Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
    Rosenthal NE; Davenport Y; Cowdry RW; Webster MH; Goodwin FK
    Psychiatry Res; 1980 Mar; 2(1):113-9. PubMed ID: 6158064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P; Verrier M; Warsh JJ; Price KS
    J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F; Agren H; Hällgren R
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
    Banki CM; Molnar G
    Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression.
    Banki CM; Molnar G; Fekete I
    Arch Psychiatr Nervenkr (1970); 1981; 229(4):345-53. PubMed ID: 6164353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms.
    Banki CM; Molnar G; Vojnik M
    J Affect Disord; 1981 Jun; 3(2):91-9. PubMed ID: 6166645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression.
    Aberg-Wistedt A; Wistedt B; Bertilsson L
    Arch Gen Psychiatry; 1985 Sep; 42(9):925-6. PubMed ID: 2412522
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances in patients with dentatorubral-pallidoluysian atrophy.
    Takeuchi Y; Matsushita H; Sakai H; Kawano H; Ochi M
    J Child Neurol; 2001 Feb; 16(2):79-82. PubMed ID: 11292229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.